
Opinion|Videos|September 3, 2025
Empowering Pharmacists in the Management of Patients With Urothelial Cancer
Listen
0:00 / 0:00
Sherry Vogt, PharmD, BCOP; and Megan Hinkley, PharmD, MBA, BCOP, discuss how pharmacists play a crucial role in managing patients with bladder cancer through treatment selection, patient education, adverse effect monitoring, and the evolving landscape of therapies including traditional chemotherapy, immunotherapy, and antibody-drug conjugates like enfortumab vedotin plus pembrolizumab.
Advertisement
0:13 Urothelial Cancer Background
9:08 Patient Education
15:45 Chemotherapy Toxicities
21:17 Unmet Needs
29:14 Antibody-Drug Conjugates
36:55 Adverse Event Management
42:30 Other Considerations
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
Nipah Outbreak in India Poses Low Global Risk Despite Lack of Approved Treatments
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Q&A: Making Plant-Based Eating Practical in Pharmacy-Led Cardiometabolic Care
5
























